BIOMAT Database Logo BIOMAT Database Logo

Bioavailability of dihydroergotamine. 1980

J Kanto

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D004087 Dihydroergotamine A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS. Agit,Angionorm,Clavigrenin,D-Tamin Retard L.U.T.,D.H.E. 45,DET MS,DHE-45,DHE-Puren,DHE-Ratiopharm,Dihydergot,Dihydroergotamin AL,Dihydroergotamine Mesylate,Dihydroergotamine Methanesulfonate,Dihydroergotamine-Sandoz,Dihytamin,Erganton,Ergomimet,Ergont,Ergotam Von Ct,Ikaran,Migranal,Orstanorm,Seglor,Tamik,Verladyn,D Tamin Retard L.U.T.,DHE 45,DHE Puren,DHE Ratiopharm,DHE45,Dihydroergotamine Sandoz,Mesylate, Dihydroergotamine,Methanesulfonate, Dihydroergotamine,Von Ct, Ergotam
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

J Kanto
Bioavailability of dihydroergotamine in man.
June 1982, British journal of clinical pharmacology,
J Kanto
Bioavailability of intranasal formulations of dihydroergotamine.
November 1999, European journal of clinical pharmacology,
J Kanto
Dihydroergotamine increases the bioavailability of orally administered etilefrine.
January 1982, European journal of clinical pharmacology,
J Kanto
The pharmacokinetics and bioavailability of subcutaneously administered dihydroergotamine, heparin and the dihydroergotamine-heparin combination.
July 1983, Thrombosis research,
J Kanto
[Comparative bioavailability of two oral forms of dihydroergotamine (author's transl)].
January 1979, Therapie,
J Kanto
Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension.
July 1980, British medical journal,
J Kanto
Low oral bioavailability of dihydroergotamine and first-pass extraction in patients with orthostatic hypotension.
November 1981, Clinical pharmacology and therapeutics,
J Kanto
[Dihydroergotamine].
January 1953, Revista de obstetricia y ginecologia de Venezuela,
J Kanto
A Phase 1, Randomized, Open-Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects.
April 2020, Headache,
J Kanto
Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group.
December 1996, Archives of neurology,
Copied contents to your clipboard!